Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response
Toll-like receptor 3 (TLR3) mediates antiviral response by recognizing double-stranded RNA. Its cytoplasmic domain is tyrosine phosphorylated upon ligand binding and initiates downstream signaling via the adapter TIR-containing adaptor inducing interferon-β (TRIF). However, the kinase responsible fo...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 109; no. 15; pp. 5791 - 5796 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
10.04.2012
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Toll-like receptor 3 (TLR3) mediates antiviral response by recognizing double-stranded RNA. Its cytoplasmic domain is tyrosine phosphorylated upon ligand binding and initiates downstream signaling via the adapter TIR-containing adaptor inducing interferon-β (TRIF). However, the kinase responsible for TLR3 phosphorylation remains unknown. We show here that Bruton's tyrosine kinase (BTK)-deficient macrophages failed to secrete inflammatory cytokines and IFN-β upon TLR3 stimulation and were impaired in clearing intracellular dengue virus infection. Mutant mice were also less susceptible to d-galactosamine/p(I:C)-induced sepsis. In the absence of BTK, TLR3-induced phosphoinositide 3-kinase (PI3K), AKT and MAPK signaling and activation of NFκB, IRF3, and AP-1 transcription factors were all defective. We demonstrate that BTK directly phosphorlates TLR3 and in particular the critical Tyr759 residue. BTK point mutations that abrogate or led to constitutive kinase activity have opposite effects on TLR3 phosphorlation. Loss of BTK also compromises the formation of the downstream TRIF/receptor-interacting protein 1 (RIP1)/TBK1 complex. Thus, BTK plays a critical role in initiating TLR3 signaling. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions: K.-G.L. and K.-P.L. designed research; K.-G.L., S.X., Z.-H.K., J.H., and M.H. performed research; O.T. and S.A. contributed new reagents/analytic tools; D.L. and K.-P.L. analyzed data; and K.-G.L. and K.-P.L. wrote the paper. Edited by Ruslan Medzhitov, Yale University School of Medicine, New Haven, CT, and approved March 5, 2012 (received for review November 23, 2011) |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1119238109 |